Cranbrook Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $923K | Hold |
1,368
| – | – | 0.17% | 69 |
|
|
2026
Q2 | $686K | Sell |
1,368
-90
| -6% | -$43.2K | 0.13% | 78 |
|
|
2026
Q1 | $717K | Hold |
1,458
| – | – | 0.15% | 72 |
|
|
2025
Q4 | $845K | Buy |
1,458
+414
| +40% | +$234K | 0.17% | 66 |
|
|
2025
Q3 | $506K | Hold |
1,044
| – | – | 0.1% | 79 |
|
|
2025
Q2 | $423K | Hold |
1,044
| – | – | 0.09% | 86 |
|
|
2025
Q1 | $519K | Sell |
1,044
-29
| -3% | -$15.7K | 0.12% | 76 |
|
|
2024
Q4 | $558K | Hold |
1,073
| – | – | 0.13% | 74 |
|
|
2024
Q3 | $664K | Hold |
1,073
| – | – | 0.15% | 69 |
|
|
2024
Q2 | $593K | Buy |
1,073
+1,007
| +1,526% | +$577K | 0.15% | 67 |
|
|
2024
Q1 | $38.4K | Hold |
66
| – | – | 0.01% | 174 |
|
|
2023
Q4 | $35K | Hold |
66
| – | – | 0.01% | 174 |
|
|
2023
Q3 | $33.4K | Hold |
66
| – | – | 0.01% | 170 |
|
|
2023
Q2 | $34.4K | Hold |
66
| – | – | 0.01% | 174 |
|
|
2023
Q1 | $38K | Hold |
66
| – | – | 0.01% | 167 |
|
|
2022
Q4 | $36.3K | Hold |
66
| – | – | 0.01% | 173 |
|
|
2022
Q3 | $33K | Hold |
66
| – | – | 0.01% | 192 |
|
|
2022
Q2 | $36K | Hold |
66
| – | – | 0.01% | 188 |
|
|
2022
Q1 | $39K | Hold |
66
| – | – | 0.01% | 202 |
|
|
2021
Q4 | $44K | Hold |
66
| – | – | 0.01% | 193 |
|
|
2021
Q3 | $38K | Buy |
66
+20
| +43% | +$11K | 0.01% | 212 |
|
|
2021
Q2 | $23K | Sell |
46
-27
| -37% | -$12.7K | 0.01% | 233 |
|
|
2021
Q1 | $33K | Buy |
73
+27
| +59% | +$12.9K | 0.01% | 215 |
|
|
2020
Q4 | $21K | Hold |
46
| – | – | 0.01% | 204 |
|
|
2020
Q3 | $20K | Hold |
46
| – | – | 0.01% | 182 |
|
|
2020
Q2 | $17K | Hold |
46
| – | – | 0.01% | 186 |
|
|
2020
Q1 | $13K | Hold |
46
| – | – | ﹤0.01% | 188 |
|
|
2019
Q4 | $15K | Hold |
46
| – | – | ﹤0.01% | 191 |
|
|
2019
Q3 | $13K | Hold |
46
| – | – | ﹤0.01% | 191 |
|
|
2019
Q2 | $14K | Hold |
46
| – | – | ﹤0.01% | 185 |
|
|
2019
Q1 | $13K | Hold |
46
| – | – | ﹤0.01% | 187 |
|
|
2018
Q4 | $10K | Hold |
46
| – | – | ﹤0.01% | 186 |
|
|
2018
Q3 | $11K | Hold |
46
| – | – | ﹤0.01% | 181 |
|
|
2018
Q2 | $10K | Buy |
+46
| New | +$9.8K | ﹤0.01% | 179 |
|
Other funds holding TMO
Cranbrook Wealth Management's TMO Position: Q3 2026 in Review
Cranbrook Wealth Management held its Thermo Fisher Scientific (TMO) position steady in Q3 2026 at 1,368 shares worth $923K. The position accounts for 0.17% of the portfolio, ranked #69.
Cranbrook Wealth Management first reported a position in TMO in Q2 2018 and has held it in 34 quarters since. 2,450 funds tracked by Wall St. Rank hold TMO as of Q3 2026.
- Cranbrook Wealth Management held 1,368 shares of Thermo Fisher Scientific worth $923K as of Q3 2026.
- Cranbrook Wealth Management left its Thermo Fisher Scientific share count unchanged in Q3 2026.
- Thermo Fisher Scientific made up 0.17% of Cranbrook Wealth Management's portfolio in Q3 2026, its #69 holding.
- Cranbrook Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2018 and has held it in 34 quarters since.
- 2,450 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.
Based on Cranbrook Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.